COVID-19 associated sick days spike in insulin requirements: the need for rapidly escalating treatment and rapidly reducing on recovery
Keywords:COVID-19, Diabetes Mellitus, severe acute respiratory syndrome coronavirus 2, hyperglycaemia, diabetic ketoacidosis
Bornstein ST, Rubinn F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RIG, Skyler JS, DeVries JH, Renard E,Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JCm Ji and Ludwig B. Practical recommendations for the management of diabetes in patients with COVID-19 Lancet Diabetes Endocrinol. 2020 Apr 23 doi: 10.1016/S2213-8587(20)30152-2 Epub ahead of print]
Diabetes UK, Concise advise on inpatient diabetes (COVID:Diabetes): Guidance for managing inpatient hyperglycaemia. Dated 29/4/2020 (Cited 2020 May 26th) Available from: https://www.diabetes.org.uk/resources-s3/public/2020-04/COvID_Hyper_v4.2.pdf
Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2009;302:193–202.
Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193–199.
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.